Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Medical Laser Technology (MLT), and Anti-Cancer Technology (ACT) segments. The MLT segment focuses on the company's medical laser business, which researches, develops, commercializes and manufactures lasers used by the ACT division. The ACT segment research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.